SIFCO Industries (NYSEAM) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
5 Oct, 2026Executive summary
H1 FY2025 net sales rose 10.9% to $39.9M from $36.0M; continuing-operations loss narrowed to $3.7M from $6.3M.
Q2 sales fell 7.3% to $19.0M from $20.5M, while continuing-operations loss narrowed to $1.3M from $2.2M.
Backlog reached $129.2M, with raw-material sourcing challenges weighing on Q2 sales.
Financial highlights
Q2 continuing-operations loss was $1.3M, or $0.22 per diluted share, versus $2.2M, or $0.38; total net loss was $1.4M, or $0.23/share.
H1 continuing-operations loss was $3.7M, or $0.62 per diluted share, versus $6.3M, or $1.05; total net loss was $3.7M, or $0.61/share.
Q2 operating loss narrowed to $0.8M from $1.3M; H1 operating loss narrowed to $2.7M from $5.0M.
Gross profit increased to $1.6M from $1.5M in Q2 and to $2.5M from $0.9M in H1.
H1 SG&A declined to $5.2M from $5.9M, reflecting lower employee, operating, legal and strategic-alternative costs.
Outlook and guidance
Management cited favorable year-to-date performance, growing backlog and strong ongoing product demand.
Q2 priorities included finding margin-improvement opportunities and increasing throughput at both plants.
Remaining FY2025 capital expenditures are expected to be $1.5M–$2.0M, mainly for production capabilities, product offerings and cost reductions.
Existing cash is expected to fund operations, planned capex and expected costs over the next 12 months; additional debt or equity funding may support growth.
Expected remaining FY2025 pension contributions are $187K in cash, with potential use of carryover balances subject to funded status and minimum funding requirements.
Latest events from SIFCO Industries
- FY24 sales rose 20%, with $114.4M backlog driving increased production.NYSEAM
Q4 2024 - Sales rose 6%, continuing losses narrowed, and year-end backlog reached $119.2m.NYSEAM
Q4 2025 - Q3 growth lifted earnings, but October debt maturity leaves refinancing risk unresolved.NYSEAM
Q3 2024 - Higher military volumes and pricing drove a sharp return to profit, with financing and environmental risks persisting.NYSEAM
Q2 2026 - Sales rose 35.0%, losses narrowed, and backlog reached $121.9M.NYSEAM
Q1 2025 - ERC benefits and aerospace demand lifted Q3 profit; backlog stood at $130.4M.NYSEAM
Q3 2025 - Four directors, auditor ratification and a pause in FY2025 long-term awards headline the proxy.NYSEAM
Proxy filing - Military demand lifted nine-month results and backlog, while Q3 earnings absorbed a $3.2 million LIFO impact.NYSEAM
Q3 2026 - Sales rose 14.8% as military demand drove a return to profit and backlog growth.NYSEAM
Q1 2026